Bookmark
Forward
Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19).
Pierre Francois Laterre, Bruno François, Christine Collienne, Philippe Hantson, Robin Jeannet, Kenneth E Remy, Richard S Hotchkiss
JAMA network open 2020 Jul 01
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Pierre Francois Laterre, Bruno François, Christine Collienne, Philippe Hantson, Robin Jeannet, Kenneth E Remy, Richard S Hotchkiss.
Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19).
JAMA network open.
2020 Jul 01;3(7):e2016485
Mesh Tags
Adult
Aged
Aged, 80 and over
Betacoronavirus
COVID-19
Case-Control Studies
Coronavirus Infections
Cytokines
Female
Humans
Immunotherapy
Interleukin-7
Lymphocyte Count
Lymphopenia
Male
Middle Aged
Outcome Assessment, Health Care
Pandemics
Pneumonia, Viral
Randomized Controlled Trials as Topic
SARS-CoV-2
Substances
Cytokines
IL7 protein, human
Interleukin-7
PMID: 32697322
View Full Text